Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1977;55:381-387

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Danahy, D. T.
Right arrow Articles by Prakash, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Danahy, D. T.
Right arrow Articles by Prakash, R.

Circulation, Vol 55, 381-387, Copyright © 1977 by American Heart Association


ARTICLES

Sustained hemodynamic and antianginal effect of high dose oral isosorbide dinitrate

DT Danahy, DT Burwell, WS Aronow and R Prakash

Twenty-one patients with documented coronary atherosclerotic heart disease were studied to determine the effect of high dose oral isosorbide dinitrate (ISDN) on heart rate, blood pressure, and exercise time until angina pectoris. Patients were tested in two phases, initially with 0.4 mg of sublingual nitroglycerin and with sublingual placebo, and then with oral ISDN, mean dose 29 mg, and oral placebo. Both phases of the study were conducted in a randomized, double-blind, crossover manner. After ISDN was compared to oral placebo, heart rate increased at 30 to 300 min (P less than 0.01) (peak increase 18 beats/min at 60 min), and systolic blood pressure decreased from 45 to 300 min (P less than 0.005) (peak decrease 18 mm Hg at 60 min). Exercise time at 2 min after sublingual nitroglycerin increased 51% as compared to oral placebo, exercise time increased 54% at 1 hr (P less than 0.005), 37% at 3 hr (P less than 0.01), and 12% at 5 hr (NS). Twelve of 21 patients (57%) improved their exercise time until angina larger than or equal to 25% at 1 hr after oral ISDN. The exercise response to sublingual nitroglycerin was a good predictor of this response to oral ISDN.


This article has been cited by other articles:


Home page
Stat Methods Med ResHome page
A. Pickles and R. Crouchlev
Generalizations and applications of frailty models for survival and event data
Statistical Methods in Medical Research, October 1, 1994; 3(3): 263 - 278.
[Abstract] [PDF]


Home page
ANN INTERN MEDHome page
N. REICHEK and ST. J. S. MARTIN
Long-Acting Nitroglycerin for Angina, 1982: Old Dog, New Tricks
Ann Intern Med, November 1, 1982; 97(5): 774 - 776.
[Abstract] [PDF]


Home page
JAMAHome page
J. A. Franciosa, L. A. Nordstrom, and J. N. Cohn
Nitrate Therapy for Congestive Heart Failure
JAMA, August 4, 1978; 240(5): 443 - 446.
[Abstract] [PDF]


Home page
Arch Intern MedHome page
J. A. Franciosa
Current Clinical Status of Nitroglycerin and Other Nitrates
Arch Intern Med, April 1, 1978; 138(4): 525 - 526.
[Abstract] [PDF]